Publication:
Reversible posterior leukoencephalopathy induced by cancer chemotherapy

dc.contributor.buuauthorBaytan, Birol
dc.contributor.buuauthorÖzdemir, Özlem
dc.contributor.buuauthorDemirkaya, Metin
dc.contributor.buuauthorEvim, Melike Sezgin
dc.contributor.buuauthorGüneş, Adalet Meral
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.contributor.researcheridAAH-1452-2021
dc.contributor.scopusid6506622162
dc.contributor.scopusid26647804400
dc.contributor.scopusid24331130000
dc.contributor.scopusid36337796600
dc.contributor.scopusid24072843300
dc.date.accessioned2021-12-16T10:33:08Z
dc.date.available2021-12-16T10:33:08Z
dc.date.issued2010-09
dc.description.abstractReversible posterior leukoencephalopathy, defined by both clinical and neuroimaging findings, can affect children receiving chemotherapy. The syndrome is characterized by hypertension, alterations in mental status, seizures, hallucinations, and acute visual changes and is associated with abnormalities seen in magnetic resonance imaging of symmetric white matter lesions, especially in the parietal and occipital lobes. The etiology of reversible posterior leukoencephalopathy is as yet unknown. Presented here are four cases of reversible posterior leukoencephalopathy induced by chemotherapy, with a brief review of the literature and consideration of possible mechanisms. A diagnosis of reversible posterior leukoencephalopathy should be considered when patients receiving cancer chemotherapy suddenly develop hypertension followed by neurologic complications, especially if presenting with seizures.
dc.identifier.citationBaytan, B. vd. (2010). "Reversible posterior leukoencephalopathy induced by cancer chemotherapy". Pediatric Neurology, 43(3), 197-201.
dc.identifier.endpage201
dc.identifier.issn0887-8994
dc.identifier.issue3
dc.identifier.pubmed20691942
dc.identifier.scopus2-s2.0-77955542463
dc.identifier.startpage197
dc.identifier.urihttps://doi.org/10.1016/j.pediatrneurol.2010.05.005
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0887899410002067
dc.identifier.urihttp://hdl.handle.net/11452/23324
dc.identifier.volume43
dc.identifier.wos000281131400009
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier Science
dc.relation.journalPediatric Neurology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcute lymphoplastic-leukemia
dc.subjectEncephalopathy syndrome
dc.subjectCortical blindness
dc.subjectChildren
dc.subjectTherapy
dc.subjectNeurosciences & neurology
dc.subjectPediatrics
dc.subject.emtreeAsparaginase macrogol
dc.subject.emtreeCytarabine
dc.subject.emtreeDexamethasone
dc.subject.emtreeMethotrexate
dc.subject.emtreePrednisone
dc.subject.emtreeVincristine
dc.subject.emtreeAcute lymphoblastic leukemia
dc.subject.emtreeAdolescent
dc.subject.emtreeArticle
dc.subject.emtreeCancer chemotherapy
dc.subject.emtreeCase report
dc.subject.emtreeChild
dc.subject.emtreeFemale
dc.subject.emtreeHallucination
dc.subject.emtreeHuman
dc.subject.emtreeHypertension
dc.subject.emtreeMale
dc.subject.emtreeMental health
dc.subject.emtreeNeuroimaging
dc.subject.emtreeNeurologic disease
dc.subject.emtreeNuclear magnetic resonance imaging
dc.subject.emtreeOccipital lobe
dc.subject.emtreeParietal lobe
dc.subject.emtreePosterior reversible encephalopathy syndrome
dc.subject.emtreePriority journal
dc.subject.emtreeSchool child
dc.subject.emtreeSeizure
dc.subject.emtreeVisual impairment
dc.subject.meshAdolescent
dc.subject.meshAntineoplastic agents
dc.subject.meshChild
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLeukoencephalopathies
dc.subject.meshMagnetic resonance imaging
dc.subject.meshMale
dc.subject.meshNeoplasms
dc.subject.scopusPosterior Reversible Encephalopathy Syndrome; Eclampsia; Hypertension Encephalopathy
dc.subject.wosClinical neurology
dc.subject.wosPediatrics
dc.titleReversible posterior leukoencephalopathy induced by cancer chemotherapy
dc.typeArticle
dc.wos.quartileQ3 (Clinical neurology)
dc.wos.quartileQ2 (Pediatrics)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: